| Unique ID issued by UMIN | UMIN000063646 |
|---|---|
| Receipt number | R000072834 |
| Scientific Title | Effects of consumption of the test food on swelling in healthy Japanese: a randomized, placebo-controlled, double-blind, crossover comparison study |
| Date of disclosure of the study information | 2026/11/16 |
| Last modified on | 2026/11/16 12:13:20 |
Effects of consumption of the test food on swelling in healthy Japanese: a randomized, placebo-controlled, double-blind, crossover comparison study
Effects of consumption of the test food on swelling in healthy Japanese: a randomized, placebo-controlled, double-blind, crossover comparison study
Effects of consumption of the test food on swelling in healthy Japanese: a randomized, placebo-controlled, double-blind, crossover comparison study
Effects of consumption of the test food on swelling in healthy Japanese
| Japan |
Healthy Japanese
| Not applicable | Adult |
Others
NO
To verify the effects of consumption of the test food on swelling in healthy Japanese.
Efficacy
Confirmatory
Pragmatic
Not applicable
1. The value of calf circumference in the evening
1. The values in the morning and the difference between evening and morning (evening minus morning) of calf circumference
2. The measured values of Visual Analogue Scale (VAS) for "I feel swelling face (cheeks or face line)," "I feel swelling around eyes," "I feel swelling calves," "I feel swelling the ankle (such as my socks feeling tight)," "I feel my complexion looks poor," and "I feel dark circles under my eyes".
3. The measured values of body weight, body mass index (BMI), body fat percentage, lean body mass, fat mass (whole body, right leg, left leg, right arm, left arm, trunk), muscle mass (whole body, right leg, left leg, right arm, left arm, trunk), and the changes and percentage changes of them from the measured values in the morning
4. Individuals who experienced adverse events
5. Physical measurements, urinalysis, and peripheral blood test
Interventional
Cross-over
Randomized
Individual
Double blind -all involved are blinded
Placebo
Institution is not considered as adjustment factor.
YES
Central registration
2
Educational,Counseling,Training
| Food |
<Duration>
Two weeks each (two test periods)
<Test product>
Test 1: Capsule containing camellia seeds extract powder
Test 2: Capsule containing dextrin
Prescribed meals: Charcoal grilled silver salmon onigiri (SEVEN-ELEVEN), Tuna mayonnaise onigiri (SEVEN-ELEVEN)
<Administration>
Test 1: Consume one capsule per day with water.
Test 2: Consume one capsule per day with water.
Prescribed meals: Consume each meal at any time between 11:00 and 13:00 on each test day.
*Washout period is two weeks or more.
*If a dose is missed, it should be consumed as soon as remembered. The daily dose should be consumed within the same day and should not be carried over to the following day.
*The intervention sequence is Test 1 to Test 2.
*The contents of the prescribed meals will be reviewed periodically, taking into account factors such as product sales performance.
<Duration>
Two weeks each (two test periods)
<Test product>
Test 1: Capsule containing dextrin
Test 2: Capsule containing camellia seeds extract powder
Prescribed meals: Charcoal grilled silver salmon onigiri (SEVEN-ELEVEN), Tuna mayonnaise onigiri (SEVEN-ELEVEN)
<Administration>
Test 1: Consume one capsule per day with water.
Test 2: Consume one capsule per day with water.
Prescribed meals: Consume each meal at any time between 11:00 and 13:00 on each test day.
*Washout period is two weeks or more.
*If a dose is missed, it should be consumed as soon as remembered. The daily dose should be consumed within the same day and should not be carried over to the following day.
*The intervention sequence is Test 1 to Test 2.
*The contents of the prescribed meals will be reviewed periodically, taking into account factors such as product sales performance.
| 18 | years-old | <= |
| Not applicable |
Male and Female
1. Japanese
2. Men or women
3. Adults
4. Healthy individuals
5. Individuals with no abnormalities in kidney function as determined by urinalysis at screening (Scr)
6. Individuals whose BMI is >=18.5 kg/m2 and <30 kg/m2
7. Individuals whose systolic blood pressure is < 130 mmHg and diastolic blood pressure is < 90 mmHg at Scr
1. Individuals who are receiving treatment for or have a history of malignant tumors, heart failure, or myocardial infarction
2. Individuals who have an implanted pacemaker or implantable cardioverter defibrillator
3. Individuals who are currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disorder, chronic kidney disease, cerebrovascular disorder, rheumatic disease, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases
4. Individuals who consume Foods for Specified Health Uses or Foods with Functional Claims
5. Individuals who are taking or using medications (including herbal medicines) or supplements
6. Individuals who are allergic to medications or foods related to the test product
7. Individuals who have irregular lifestyles by night work, shift work, or others
8. Individuals who take foods/beverages, medications, or others that may affect swelling
9. Individuals whose menstrual cycle has been < 25 days or > 38 days in the last two menstrual cycles
10. Individuals whose working form is outside work, such as outdoor works or sales calls
11. Individuals who are pregnant, lactating, or planning pregnancy during this study
12. Individuals who have participated in other clinical studies within 28 days before informed consent, or plan to participate in another study during this study
13. Individuals who are deemed unsuitable for participation in this study by the principal investigator
30
| 1st name | Tsuyoshi |
| Middle name | |
| Last name | Takara |
Medical Corporation Seishinkai, Takara Clinic
Director
141-0022
9F Taisei Bldg., 2-3-2, Higashi-gotanda, Shinagawa-ku, Tokyo, Japan
03-5793-3623
t-takara@takara-clinic.com
| 1st name | Naoko |
| Middle name | |
| Last name | Suzuki |
ORTHOMEDICO Inc.
R&D Department
112-0002
2F Sumitomo Fudosan Korakuen Bldg., 1-4-1, Koishikawa, Bunkyo-ku, Tokyo, Japan
03-3818-0610
nao@orthomedico.jp
Iwase Cosfa Co.,Ltd.
Iwase Cosfa Co.,Ltd.
Profit organization
The ethical committee of the Takara Clinic, Medical Corporation Seishinkai
9F Taisei Bldg., 2-3-2, Higashi-gotanda, Shinagawa-ku, Tokyo, Japan
03-5793-3623
IRB@takara-clinic.com
NO
医療法人社団盛心会 タカラクリニック (東京都)
Medical Corporation Seishinkai, Takara Clinic (Tokyo, Japan)
南町医院 (東京都)
Nerima Medical Association, Minami-machi Clinic (Tokyo, Japan)
| 2026 | Year | 11 | Month | 16 | Day |
Unpublished
Open public recruiting
| 2026 | Year | 10 | Month | 21 | Day |
| 2026 | Year | 10 | Month | 21 | Day |
| 2026 | Year | 11 | Month | 16 | Day |
| 2027 | Year | 03 | Month | 08 | Day |
| 2026 | Year | 11 | Month | 16 | Day |
| 2026 | Year | 11 | Month | 16 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072834